Gold Price Shrugs Off ‘Better Than Pfizer’ Covid Vaccine News as Top 2 ETFs Shrink 1st Time Since March

GOLD PRICES dropped from near a one-week high Monday lunch time in London as interest rate jumped after last week’s vacccine news was followed by better-still results from separate Covid-drug trials, writes Atsuko Whitehouse at BullionVault.

US biotech Moderna (Nasdaq: MRNA) today said its Covid-19 vaccine has shown 94.5% efficacy in clinical trials, beating the 90% effectiveness claims last Monday by giant US pharma Pfizer (NYSE: PFE) and without needing the super-cold storage now spurring a race to buy medical freezer units.

Dropping to $1865 after testing $1900 per ounce, gold prices then rebounded, reaching last week’s closing level of $1889.

Ten-year US Treasury yields meantime rose 2 basis points to 0.92%, but held below the 8-month high of 0.97% reached on the Pfizer news last week."A vaccine with a greater than 90% rate is another form of stimulus that you have to weigh in," reckons Bob Michele, chief investment officer […]

Click here to view original web page at www.bullionvault.com

About the author: StockMan

Please remember:

The information provided here is for general knowledge and educational purposes only.
It is not intended to be a substitute for professional financial advice.
Every individual's financial situation is unique, and what works for one person may not work for another.
Before making any investment or financial decisions, you should always consult with a qualified financial advisor who understands your specific circumstances and goals.

Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, should never be acted upon. Please be aware that any information posted on this site should not be considered to be financial advice and i am not a financial advisor.